Appointment of Non-Executive Director
Nanoco Group plc (AIM: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, announces the appointment of Robin Williams as an independent Non-Executive Director.
Robin brings to Nanoco a breadth of corporate experience, gained at quoted and private businesses and in the City where he worked in investment banking during his early career. He is currently a non-executive director at Xaar plc, the Cambridge based inkjet print-head manufacturer. In addition, he chairs two businesses owned by the Department of Health, NHS Professionals Ltd and NHS Property Services Ltd. He is also a non-executive at a quoted venture capital trust and at a privately owned agricultural business.
Robin qualified as an accountant in 1981 after graduating in engineering science. He worked in corporate finance for ten years at investment banks including Salomon Brothers and UBS before leaving the City in 1992 to co-found the packaging business Britton Group plc. In 1998, he moved to Hepworth plc, the building materials group, and since 2004 he has focused on non-executive work in public, private and PE-backed businesses.
It is intended that Robin will chair Nanoco’s audit committee.
Tony Clinch, Nanoco’s Chairman, said: “We’re delighted to welcome Robin Williams to Nanoco’s Board as a Non-Executive Director. Robin has a huge breadth of corporate experience and we look forward to his contribution to the Company.”
The following information is disclosed pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies. Robin George Walton Williams, age 57 years, has been a director of the following companies during the five years preceding the date of this announcement:
Current directorships
AH Worth & Co Ltd
Baronsmead VCT 4 plc
NHS Professionals Ltd
NHS Property Services Ltd
Xaar plc
26 Gledhow Gardens Ltd
Past directorships
Constantine Group plc
Killby & Gayford Group Ltd
Cagney plc
Maxima Holdings plc
London Linen Supply Ltd
DCI Inc.
Bio Products Laboratory Holdings Ltd
Bio Products Laboratory Ltd
PRUK Ltd
Further information to be disclosed: Killby & Gayford Group (covering Killby & Gayford Consolidation, Killby & Gayford Holdings and Killby & Gayford Ltd.) entered into administration in April 2012, approximately seven months following Robin’s resignation as non-executive chairman. Killby & Gayford Group traded profitably throughout Robin’s tenure.
There is no further information to be disclosed pursuant to Rule 17 or Schedule Two paragraph (g) of the AIM Rules for Companies.
For further information please contact:
Nanoco
Michael Edelman, Chief Executive Officer
Colin White, Chief Financial Officer
+ 44 (0) 161 603 7900
Canaccord Genuity – Nomad and Joint Broker
Simon Bridges
Cameron Duncan
+44 (0) 20 7523 8000
Liberum Capital – Joint Broker
Simon Atkinson
Richard Bootle
+44 (0) 20 3100 2000
Buchanan
Mark Court / Fiona Henson / Sophie Cowles
+ 44 (0) 20 7466 5000
Notes for editors:
About Nanoco Group plc
Nanoco is a world leader in the development and production of cadmium-free quantum dots and other nano-materials for use in multiple applications including LCD displays, lighting, solar cells and bio-imaging. In the display market, it has an exclusive manufacturing and marketing licensing agreement with The Dow Chemical Company.
Nanoco was founded in 2001 and is headquartered in Manchester, UK. It has production facilities in Runcorn, UK, and a US subsidiary, Nanoco Inc, based in Concord, MA. Nanoco also has business development offices in Japan, Korea and Taiwan. Its technology is protected worldwide by a large and growing patent estate.
Nanoco began trading on the AIM market of the London Stock Exchange in May 2009 under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.
